OriGene Technologies
PrivateLast Round
Private Equity
May 4, 2020
Total Funding Raised
$37.3M
Company Overview
OriGene Technologies operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Private Equity round in May 2020.
OriGene Technologies is a biotechnology company that develops, manufactures, and sells genome-wide research and diagnostic products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OriGene Technologies Comparables
Compare OriGene Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneCopoeia, Inc. | 84% | |
| Sino Biological Inc. | 81% | |
| Abcam | 79% |
For institutional investors. Book with your work email.
OriGene Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 4, 2020 | ||||
| Series C | Mar 21, 2013 | ||||
| Series B | Mar 17, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OriGene Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Private Equity |
| IDG Capital | Private Equity, Series C, Series B |
| Kleiner Perkins China | Series C |
| Morningside Ventures | Series B, Series A |
| Zero2IPO Group | Series B |
| Qiming Venture Partners | Series C |
| Mérieux Equity Partners | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 31% MoM to 121.4K.
- Mar 9, 2025
Monthly visitors increased 31% MoM, reaching 92.4K.
For institutional investors. Book with your work email.
OriGene Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OriGene Technologies's valuation, stock price, and market status.
Is OriGene Technologies a public or private company?
OriGene Technologies is a private company.
What is the current stock price of OriGene Technologies?
OriGene Technologies is a private company, so its shares have no public market price. Caplight tracks OriGene Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OriGene Technologies worth (valuation)?
Valuation information for OriGene Technologies is not publicly available.
Can I buy OriGene Technologies stock?
OriGene Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OriGene Technologies's last funding round?
OriGene Technologies's most recent funding round was Private Equity on May 4, 2020.
Who are the main investors in OriGene Technologies?
Key investors in OriGene Technologies include Cathay Capital, IDG Capital, Kleiner Perkins China, Zero2IPO Group, Qiming Venture Partners.
Will OriGene Technologies IPO soon?
No public IPO plans have been announced for OriGene Technologies.
How can I track OriGene Technologies secondary market activity?
Caplight tracks bids, offers, and trades in OriGene Technologies's shares on secondary markets.